RecruitingNCT06306170
Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Efficacy of Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Sponsor
IRCCS San Raffaele
Enrollment
1,000 participants
Start Date
Feb 15, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years
Inclusion Criteria3
- gynecologic cancer patients
- >18 years old
- treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT)
Exclusion Criteria2
- other tumors
- > 90 years old
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
RADIATIONImage Guided Radiotherapy
Patients treated with IGRT, IMRT, SBRT for Gynecological cancer will be evaluated
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06306170
Related Trials
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
NCT074543307 locations
Danish Vulva Cancer Recurrence Study
NCT064955542 locations
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
NCT072640361 location
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
NCT070306864 locations
The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population
NCT075588891 location